Begin typing your search...
J and J withdraws vaccine approval proposal
Global healthcare major Johnson & Johnson on Monday withdrew its application to conduct bridging clinical studies of its vaccine in India after the Centre waived the requirement of trials for foreign vaccines.
By
migrator
migrator
New Delhi
However, the company said that it remains committed to bringing its single-dose COVID vaccine to India and looks forward to ongoing discussions with the government. “Since the DCGI recently directed that there is no longer a requirement to conduct bridging clinical studies of vaccines in India, Johnson & Johnson withdrew its application,” the company said.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
Next Story
